Growing community of inventors

Secane, PA, United States of America

Matthew Seavey

Average Co-Inventor Count = 3.27

ph-index = 7

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 91

Matthew SeaveyYvonne Paterson (8 patents)Matthew SeaveyPaulo Cesar Maciag (8 patents)Matthew SeaveyDuane Sewell (5 patents)Matthew SeaveyAnu Wallecha (2 patents)Matthew SeaveyVafa Shahabi (2 patents)Matthew SeaveyPawel T Dobrzanski (2 patents)Matthew SeaveySoldano Ferrone (1 patent)Matthew SeaveyBruce A Ruggeri (1 patent)Matthew SeaveyNicola Mason (1 patent)Matthew SeaveyPaulo MaCiag (1 patent)Matthew SeaveyMatthew Seavey (11 patents)Yvonne PatersonYvonne Paterson (45 patents)Paulo Cesar MaciagPaulo Cesar Maciag (13 patents)Duane SewellDuane Sewell (6 patents)Anu WallechaAnu Wallecha (10 patents)Vafa ShahabiVafa Shahabi (7 patents)Pawel T DobrzanskiPawel T Dobrzanski (2 patents)Soldano FerroneSoldano Ferrone (28 patents)Bruce A RuggeriBruce A Ruggeri (7 patents)Nicola MasonNicola Mason (6 patents)Paulo MaCiagPaulo MaCiag (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Pennsylvania (8 from 2,595 patents)

2. Cephalon, Inc. (3 from 247 patents)

3. Advaxis, Inc. (2 from 20 patents)


11 patents:

1. 10695410 - Compositions comprising angiogenic factors and methods of use thereof

2. 9981024 - Compositions comprising angiogenic factors and methods of use thereof

3. 9919038 - Compositions comprising angiogenic factors and methods of use thereof

4. 9408898 - Compositions comprising angiogenic factors and methods of use thereof

5. 9340559 - Proteasome inhibitor delanzomib for use in the treatment of lupus

6. 9084747 - Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors

7. 9034876 - Treatment of chronic inflammation with a 1,2,4-triazolo [1,5a] pyridine derivative

8. 9023853 - Janus kinase 2 (JAK2) inhibitor for the treatment of lupus

9. 9017660 - Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors

10. 8778329 - Compositions comprising angiogenic factors and methods of use thereof

11. 8268326 - Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…